The Pros and Cons of Allowing the Federal Government to Negotiate Prescription Drug Prices
Description:
The Medicare Prescription Drug, Improvement, and Modernization Act (MMA)
expressly forbids the Secretary of Health and Human Services (HHS) from negotiating
the price of prescription drugs on behalf of Medicare beneficiaries. This report outlines
the arguments for and against allowing the federal government to negotiate prescription
drug prices on behalf of Medicare beneficiaries. This report will be updated, as needed.
Date:
February 18, 2005
Creator:
Hahn, Jim
Partner:
UNT Libraries Government Documents Department